These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31622747)

  • 21. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
    Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
    Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.
    Chicca A; Arena C; Manera C
    Recent Pat CNS Drug Discov; 2016; 10(2):122-141. PubMed ID: 27630088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Reversible-Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold.
    Rong J; Mori W; Xia X; Schafroth MA; Zhao C; Van RS; Yamasaki T; Chen J; Xiao Z; Haider A; Ogasawara D; Hiraishi A; Shao T; Zhang Y; Chen Z; Pang F; Hu K; Xie L; Fujinaga M; Kumata K; Gou Y; Fang Y; Gu S; Wei H; Bao L; Xu H; Collier TL; Shao Y; Carson RE; Cravatt BF; Wang L; Zhang MR; Liang SH
    J Med Chem; 2021 Oct; 64(19):14283-14298. PubMed ID: 34569803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase.
    Liu X; Chen Y; Vickstrom CR; Li Y; Viader A; Cravatt BF; Liu QS
    Sci Rep; 2016 Oct; 6():35829. PubMed ID: 27775008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoacylglycerol lipase - a target for drug development?
    Fowler CJ
    Br J Pharmacol; 2012 Jul; 166(5):1568-85. PubMed ID: 22428756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase.
    Butler CR; Beck EM; Harris A; Huang Z; McAllister LA; Am Ende CW; Fennell K; Foley TL; Fonseca K; Hawrylik SJ; Johnson DS; Knafels JD; Mente S; Noell GS; Pandit J; Phillips TB; Piro JR; Rogers BN; Samad TA; Wang J; Wan S; Brodney MA
    J Med Chem; 2017 Dec; 60(23):9860-9873. PubMed ID: 29148769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.
    Afzal O; Kumar S; Kumar R; Firoz A; Jaggi M; Bawa S
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3986-96. PubMed ID: 25011912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review on Structurally Diversified Synthesized Molecules as Monoacylglycerol Lipase Inhibitors and their Therapeutic uses.
    Kashyap A; Kumar S; Dutt R
    Curr Drug Res Rev; 2022; 14(2):96-115. PubMed ID: 35232358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.
    Granchi C; Lapillo M; Glasmacher S; Bononi G; Licari C; Poli G; El Boustani M; Caligiuri I; Rizzolio F; Gertsch J; Macchia M; Minutolo F; Tuccinardi T; Chicca A
    J Med Chem; 2019 Feb; 62(4):1932-1958. PubMed ID: 30715876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel monoacylglycerol lipase-targeted
    Cheng R; Fujinaga M; Yang J; Rong J; Haider A; Ogasawara D; Van RS; Shao T; Chen Z; Zhang X; Calderon Leon ER; Zhang Y; Mori W; Kumata K; Yamasaki T; Xie L; Sun S; Wang L; Ran C; Shao Y; Cravatt B; Josephson L; Zhang MR; Liang SH
    Acta Pharmacol Sin; 2022 Nov; 43(11):3002-3010. PubMed ID: 35513432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
    Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
    J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
    Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
    Granchi C; Bononi G; Ferrisi R; Gori E; Mantini G; Glasmacher S; Poli G; Palazzolo S; Caligiuri I; Rizzolio F; Canzonieri V; Perin T; Gertsch J; Sodi A; Giovannetti E; Macchia M; Minutolo F; Tuccinardi T; Chicca A
    Eur J Med Chem; 2021 Jan; 209():112857. PubMed ID: 33045662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoacylglycerol Lipase Regulates Fever Response.
    Sanchez-Alavez M; Nguyen W; Mori S; Moroncini G; Viader A; Nomura DK; Cravatt BF; Conti B
    PLoS One; 2015; 10(8):e0134437. PubMed ID: 26287872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging.
    He Y; Schild M; Grether U; Benz J; Leibrock L; Heer D; Topp A; Collin L; Kuhn B; Wittwer M; Keller C; Gobbi LC; Schibli R; Mu L
    J Med Chem; 2022 Feb; 65(3):2191-2207. PubMed ID: 35089028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
    Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
    Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase.
    Aaltonen N; Savinainen JR; Ribas CR; Rönkkö J; Kuusisto A; Korhonen J; Navia-Paldanius D; Häyrinen J; Takabe P; Käsnänen H; Pantsar T; Laitinen T; Lehtonen M; Pasonen-Seppänen S; Poso A; Nevalainen T; Laitinen JT
    Chem Biol; 2013 Mar; 20(3):379-90. PubMed ID: 23521796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).
    Aaltonen N; Kedzierska E; Orzelska-Górka J; Lehtonen M; Navia-Paldanius D; Jakupovic H; Savinainen JR; Nevalainen T; Laitinen JT; Parkkari T; Gynther M
    J Pharmacol Exp Ther; 2016 Oct; 359(1):62-72. PubMed ID: 27451409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain.
    He Y; Grether U; Taddio MF; Meier C; Keller C; Edelmann MR; Honer M; Huber S; Wittwer MB; Heer D; Richter H; Collin L; Hug MN; Hilbert M; Postmus AGJ; Stevens AF; van der Stelt M; Krämer SD; Schibli R; Mu L; Gobbi LC
    Eur J Med Chem; 2022 Dec; 243():114750. PubMed ID: 36137365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.